Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Mayne Pharma Group ( (AU:MYX) ) has provided an announcement.
Mitsubishi UFJ Financial Group, Inc. has ceased to be a substantial holder in Mayne Pharma Group Limited as of June 19, 2025. This change in holding is due to a series of transactions involving the purchase and sale of securities by entities controlled by Morgan Stanley, which affected the voting securities of Mayne Pharma Group. The implications of this change could influence the company’s market dynamics and shareholder structure.
The most recent analyst rating on (AU:MYX) stock is a Buy with a A$7.09 price target. To see the full list of analyst forecasts on Mayne Pharma Group stock, see the AU:MYX Stock Forecast page.
More about Mayne Pharma Group
Average Trading Volume: 942,293
Technical Sentiment Signal: Sell
Current Market Cap: A$433.9M
For a thorough assessment of MYX stock, go to TipRanks’ Stock Analysis page.